Showing results (41-50 of 366) with videos related to

Sort By:
Pageof 37
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2022
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel studyDolores Isla, Enriqueta Felip, Pilar Garrido, et al.
Open Respiratory Archives|February 18, 2026
Immune Checkpoint Inhibitors and Interstitial Lung Disease: A Comprehensive Review of Pathogenesis, Diagnosis, and ManagementMaría Florencia Pilia, Enriqueta Felip, David Espejo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2025
Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)Cesare Gridelli, Tony Mok, Pasi Jänne, et al.
Oncology (Williston Park, N.Y.)|September 2, 2004
Pemetrexed in previously treated non-small-cell lung cancerRafael Rosell, Jose Miguel Sanchez, Miquel Taron, et al.
Advances in Therapy|June 21, 2025
Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C MutationDivyan Chopra, Zhiyi Lan, David M Waterhouse, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2011
Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meetingCesare Gridelli, Rolf Stahel, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|August 5, 2008
Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancerAndrew Bottomley, Channa Debruyne, Enriqueta Felip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgeryRafael Rosell, Enriqueta Felip, Miquel Taron, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390)Janessa Laskin, Lucio Crinò, Enriqueta Felip, et al.
Future Oncology (London, England)|July 11, 2022
Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomasMartin Wermke, Enriqueta Felip, Valentina Gambardella, et al.
Pageof 37